XEQUEL Trademark

Trademark Overview


On Tuesday, May 3, 2022, a trademark application was filed for XEQUEL with the United States Patent and Trademark Office. The USPTO has given the XEQUEL trademark a serial number of 97392449. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, May 30, 2024. This trademark is owned by Xequel Bio, Inc.. The XEQUEL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical and biological preparations utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, namely, ophthalmic eye drops useful in treating corneal injuries or ocular injury due to chemical agents, dermatological topical formulations useful in treating cutaneous radiation injuries, cutaneous scarring, and thermal burns, and inhalation solutions useful in treating acute lung injuries

biopharmaceutical research and development services utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, in the fields of dermatology, ophthalmology, and pulmonology
xequel

General Information


Serial Number97392449
Word MarkXEQUEL
Filing DateTuesday, May 3, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, May 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and Servicespharmaceutical and biological preparations utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, namely, ophthalmic eye drops useful in treating corneal injuries or ocular injury due to chemical agents, dermatological topical formulations useful in treating cutaneous radiation injuries, cutaneous scarring, and thermal burns, and inhalation solutions useful in treating acute lung injuries
Pseudo MarkSEQUEL
Goods and Servicesbiopharmaceutical research and development services utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, in the fields of dermatology, ophthalmology, and pulmonology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXequel Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMount Pleasant, SC 29464

Party NameXequel Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMount Pleasant, SC 29464

Trademark Events


Event DateEvent Description
Friday, May 6, 2022NEW APPLICATION ENTERED
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 22, 2023ASSIGNED TO EXAMINER
Wednesday, March 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023SOU EXTENSION 1 FILED
Wednesday, November 29, 2023SOU EXTENSION 1 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 30, 2024SOU EXTENSION 2 FILED
Thursday, May 30, 2024SOU EXTENSION 2 GRANTED
Friday, May 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED